Natera (NTRA) Liabilities and Shareholders Equity (2014 - 2026)
Natera's (NTRA) quarterly Liabilities and Shareholders Equity came in at $2.7 billion in Q2 2026, up 51.25% on a YoY basis from $1.8 billion in Q2 2025, and up 1.65% quarter-over-quarter from $2.6 billion in Q1 2026.
Analysis
Natera (NTRA) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Liabilities and Shareholders Equity for 13 consecutive years, with $2.7 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 51.25% year-over-year to $2.7 billion; the trailing twelve-month figure through Jun 2026 stood at $9.5 billion (up 40.8% YoY), and the FY2025 full-year result was $2.4 billion, up 44.41% from the prior year.
- Liabilities and Shareholders Equity climbed to $2.7 billion in Q2 2026 per NTRA's latest filing, from $2.6 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $2.7 billion in Q2 2026 and bottomed at $1.0 billion in Q3 2022.
- Historically, Liabilities and Shareholders Equity has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2024.
- The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity declined 23.05% in 2022, then surged 51.25% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then increased by 3.39% to $1.4 billion in 2023, then increased by 15.19% to $1.7 billion in 2024, then surged by 44.41% to $2.4 billion in 2025, then climbed by 10.81% to $2.7 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.7 billion, $2.6 billion, and $2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 2.66 Bn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 16.94 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 18.53 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 1.91 Bn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 2.37 Bn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 1.23 Bn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 3.31 Bn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 729.70 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 640.68 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.66 Bn |
| Mar 31, 2026 | 2.61 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 1.82 Bn |
| Jun 30, 2025 | 1.76 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 1.66 Bn |
| Sep 30, 2024 | 1.59 Bn |
| Jun 30, 2024 | 1.52 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.44 Bn |
| Sep 30, 2023 | 1.45 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.32 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Mar 31, 2022 | 1.14 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 1.31 Bn |